<DOC>
	<DOCNO>NCT01482000</DOCNO>
	<brief_summary>The purpose study compare exercise capacity pulmonary function test parameter Chronic Obstructive Pulmonary Disease ( COPD ) patient underwent usual care without pulmonary daoyin therapy China community .</brief_summary>
	<brief_title>Does Pulmonary Daoyin China Give Additional Benefit Over Usual Therapy Management Stable Chronic Obstructive Pulmonary Disease ?</brief_title>
	<detailed_description>This multicenter , randomize , none-blind , control study evaluate effect pulmonary daoyin therapy moderate severe COPD subject . Following 14 day run-in period , approximately 464 subject randomly assign none-blind treatment 3 month . The primary measure efficacy Exercise Capacity ( 6MWD ) spirometric value ( e.g . FEV1 ) . Secondary efficacy measure include Dyspnea ( MMRC ) , Quality life ( CAT , SF-36 ) , frequency exacerbation . Safety assess collection adverse event . There total 4 study visit ( randomization , 1,2,3 month treatment ) .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>A confirmed diagnosis moderate severe COPD . Age 40 80 year . Without participation interventional trial previous one month . With informed consent sign . Patients poor mobility exercise , i.e . wheelchair bound . Pregnant breastfeed woman . Resting pulmonary artery pressure &gt; 45mmHg . Any psychiatric condition render patient unable understand nature , scope possible consequence study . Patients severe comorbidities , include acute myocardial infarction unstable angina pectoris . Patients post exercise syncope osteoarthrosis affect movement . Complicated severe heart failure ( class II IV NYHA heart function ) . Complicated bronchial asthma , bronchiectasis active tuberculosis ; Complicated obliterative bronchiolitis diffuse pantothenic bronchiolitisï¼Œ Complicated pneumothorax , pleural effusion pulmonary embolism . Complicated neuromuscular disorder affect respiration . Complicated tumor . Complicated serious hepatic renal disease . Long period bed rest . Participating trial allergic use medicine .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Pulmonary Disease , Chronic Obstructive</keyword>
	<keyword>Adult</keyword>
	<keyword>therapeutic use</keyword>
	<keyword>Humans</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>daoyin therapy</keyword>
</DOC>